🧪
hypothesis

Nrf2 Pathway Activation Compensates for Progranulin Haploinsufficiency in FTD-GRN

Hypothesis

Nrf2 Pathway Activation Compensates for Progranulin Haploinsufficiency in FTD-GRN

Repurposing DMF or omaveloxolone to activate Nrf2-ARE pathway, upregulating antioxidant response elements to restore lysosomal function and suppress neuroinflammation in GRN haploinsufficiency.
🧬 NFE2L2🩺 neurodegeneration🎯 Composite 63%💱 $0.57▼8.1%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.65 (15%) Evidence 0.60 (15%) Novelty 0.55 (12%) Feasibility 0.65 (12%) Impact 0.60 (12%) Druggability 0.75 (10%) Safety 0.60 (8%) Competition 0.70 (6%) Data Avail. 0.55 (5%) Reproducible 0.65 (5%) KG Connect 0.50 (8%) 0.630 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite63%

🧪 Overview

Repurposing DMF or omaveloxolone to activate Nrf2-ARE pathway, upregulating antioxidant response elements to restore lysosomal function and suppress neuroinflammation in GRN haploinsufficiency. Moderate priority with orphan drug pathway but challenged by prior Nrf2 activator failures in CNS indications.

🧬 Mechanism

No curated mechanism pathway recorded for this hypothesis.

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
Grn knockout mice show increased oxidative stress markers and lipofuscinosis
PMID:23209436
Supports
Nrf2 activation via dimethyl fumarate reduces neuroinflammation in preclinical models
PMID:31624164
Supports
Progranulin regulates lysosomal function via mTORC1 signaling
PMID:27845330
Contradicts
Grn knockout mice do not fully recapitulate human FTD-GRN haploinsufficiency phenotypes with inconsistent neurodegeneration
Contradicts
DMF failed in multiple sclerosis and Crohn's disease trials despite strong preclinical rationale
Contradicts
Nrf2 hyperactivation can disrupt cellular iron homeostasis and increase oxidative stress via pro-oxidant effects
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — NFE2L2

No curated PDB or AlphaFold mapping for NFE2L2 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NFE2L2 →

No DepMap CRISPR Chronos data found for NFE2L2.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
↘
Falling
7d Momentum
▼ 1.1%
Volatility
Low
0.0014
Events (7d)
3
Price History
▼8.1%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

View on SciDEX ↗